Preparation of novel hollow mesoporous silica spheres and their sustained-release property
Source abstract
Abstract
Novel hollow mesoporous silica spheres (HMSs) with uniform size and morphology have been successfully synthesized in a facile route using poly(vinylpyrrolidone) (PVP) and cetyltrimethylammonium bromide (CTAB) as co-templates at room temperature. XRD, N2 adsorption–desorption analysis, FE-SEM, and TEM are used for the characterization of the structure. The hexagonally ordered pore channels are formed on the shell. Ibuprofen (IBU) as a model drug is used to examine the storage capacity and the release behaviour of drug molecules. The storage capacity of hollow mesoporous silica spheres can reach 1133 ± 52.4 mg g−1 for ibuprofen, which is three times higher than that of conventional mesoporous materials previously reported (337 mg g−1), and the storage capacity is adjustable in a wide range. Furthermore, this system also shows a sustained-release behaviour. The release rates from the IBU-HMSs system (IBU stored in HMSs) increase with the decrease of pH values and the release process follows a Fick's law.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Mesoporous Materials and Catalysis · Analytical Chemistry and Chromatography · Metal-Organic Frameworks: Synthesis and Applications
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (42)
Show source-provided references
1. Colombo P · Eur. J. Drug Metab. Pharmacokinet. · 1996 · 2 · 8710.1007/BF03190256 ↗
2. Rathbone M J · Modified Release Drug Delivery Technology · 2003
3. 10.1002/anie.20039010810.1002/anie.200390108 ↗
4. 10.1016/S0169-409X(00)00124-110.1016/S0169-409X(00)00124-1 ↗
5. 10.1016/S1461-5347(00)00268-610.1016/S1461-5347(00)00268-6 ↗
6. 10.1016/S0169-409X(01)00154-510.1016/S0169-409X(01)00154-5 ↗
7. Couvreur P · Eur. J. Pharm. Biopharm. · 1995 · 41 · 2
8. 10.1038/359710a010.1038/359710a0 ↗
9. 10.1006/jcis.1997.492610.1006/jcis.1997.4926 ↗
10. 10.1016/j.jnoncrysol.2004.06.00410.1016/j.jnoncrysol.2004.06.004 ↗
11. 10.1016/S0142-9612(99)00148-910.1016/S0142-9612(99)00148-9 ↗
12. 10.1002/(SICI)1097-4636(199902)44:2<162::AID-JBM6>3.0.CO;2-P10.1002/(SICI)1097-4636(199902)44:2<162::AID-JBM6>3.0.CO;2-P ↗
13. 10.1002/adma.20040077110.1002/adma.200400771 ↗
14. 10.1021/cm001155910.1021/cm0011559 ↗
15. 10.1021/cm021217q10.1021/cm021217q ↗
16. 10.1016/j.micromeso.2003.12.01210.1016/j.micromeso.2003.12.012 ↗
17. 10.1002/chem.20030476410.1002/chem.200304764 ↗
18. Tourné-Péteilh C · Chem. Phys. Chem. · 2003 · 3 · 28110.1002/cphc.200390045 ↗
19. 10.1021/ja028650l10.1021/ja028650l ↗
20. 10.1021/cm981061n10.1021/cm981061n ↗
21. 10.1023/A:102076431996310.1023/A:1020764319963 ↗
22. 10.1039/b307046h10.1039/b307046h ↗
23. 10.1038/nature0136210.1038/nature01362 ↗
24. 10.1021/cm034329610.1021/cm0343296 ↗
25. 10.1016/j.jconrel.2004.03.00510.1016/j.jconrel.2004.03.005 ↗
26. 10.1557/JMR.2005.003510.1557/JMR.2005.0035 ↗
27. 10.1016/j.materresbull.2005.02.01110.1016/j.materresbull.2005.02.011 ↗
28. 10.1021/ja015875810.1021/ja0158758 ↗
29. Chen J · Inorg. Chem. Commun. · 2004 · 44710.1016/j.inoche.2004.01.003 ↗
30. 10.1016/S1359-0294(00)00089-310.1016/S1359-0294(00)00089-3 ↗
31. Yu C · Chem. Lett. · 2002 · 6210.1246/cl.2002.62 ↗
32. Lin H-P · Chem. Commun. · 2001 · 197010.1039/b104600b ↗
33. 10.1021/nl034134x10.1021/nl034134x ↗
34. Schacht S · Science · 1996 · 273 · 76810.1126/science.273.5276.768 ↗
35. Fowler C E · Chem. Commun. · 2001 · 202810.1039/b104879c ↗
36. 10.1016/j.jconrel.2004.06.00510.1016/j.jconrel.2004.06.005 ↗
37. Peppas N A · Pharm. Acta Helv. · 1985 · 60 · 110
38. 10.1023/A:102298393254810.1023/A:1022983932548 ↗
39. 10.1038/359710a010.1038/359710a0 ↗
40. 10.1021/la000176e10.1021/la000176e ↗
41. 10.1021/la000834v10.1021/la000834v ↗
42. 10.1021/la010201w10.1021/la010201w ↗